Antimicrobial resistance and pathogen distribution in hospitalized burn patients: A multicenter study in Southeast China

Medicine
Lin LiXiao-Dong Chen

Abstract

Burn infections pose a serious obstacle to recovery. To investigate and analyze the antimicrobial resistance and distribution of pathogenic bacteria among hospitalized burn patients. A 3-year retrospective study was conducted in the southeast of China.The electronic medical records system was used to collect all clinical data on 1449 hospitalized patients from Fujian Medical University Union Hospital, the 180th Hospital of Chinese People's Liberation Army (PLA), the 92nd Hospital of PLA, and the First Hospital of Longyan City.A total of 1891 strains of pathogenic bacteria were detected from 3835 clinical specimens, and the total detection rate was 49.3% (1891/3835). The main pathogens were gram-negative bacteria (1089 strains; 57.6%), followed by gram-positive bacteria (689 strains; 36.4%), and fungi (113 strains; 6.0%). The predominant five bacteria were Staphylococcus aureus (19.0%), Acinetobacter baumannii (17.6%), Pseudomonas aeruginosa (16.7%), Klebsiella pneumoniae (7.4%), and Enterococcus faecalis (4.5%). Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 74.1% (265/359) of S aureus isolates. Staphylococcus epidermidis accounted for 40.6% (69/170) of coagulase-negative staphylococcal isolates, 72.5% (50/69)...Continue Reading

References

Feb 1, 1987·The Journal of Trauma·J Shelby, S W Merrell
Oct 28, 1998·The Journal of Burn Care & Rehabilitation·M D PeckD Heimbach
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L C McDonaldW R Jarvis
Apr 29, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Bin WangZhi-Lan Yuan
Sep 10, 2005·The Journal of Burn Care & Rehabilitation·Louis J Magnotti, Edwin A Deitch
Mar 29, 2006·Journal of Burn Care & Research : Official Publication of the American Burn Association·Amanda E HodleRosie M Thompson
Dec 12, 2007·Antimicrobial Agents and Chemotherapy·Christian G GiskeUNKNOWN ReAct-Action on Antibiotic Resistance
Jan 27, 2009·Burns : Journal of the International Society for Burn Injuries·Merlin GuggenheimPietro Giovanoli
Jun 3, 2009·Burns : Journal of the International Society for Burn Injuries·Yu WangKai-Yang Lv
Jan 5, 2010·Burns : Journal of the International Society for Burn Injuries·Edward F KeenClinton K Murray
Feb 26, 2010·Journal of Burn Care & Research : Official Publication of the American Burn Association·Anuradha RajputRaj Kumar Singh
Mar 11, 2011·Burns : Journal of the International Society for Burn Injuries·Ezzatollah RezaeiHassan Aliakbarian
Jul 17, 2012·Burns : Journal of the International Society for Burn Injuries·Feng-Jun SunPeiyuan Xia
Jan 5, 2013·International Journal of Medical Sciences·Yasemin BayramIrfan Bayram
Feb 26, 2013·BMC Infectious Diseases·Lisa DanzmannRalf-Peter Vonberg
Apr 9, 2013·Enfermedades infecciosas y microbiología clínica·Javier Pemán, Miquel Salavert
May 15, 2013·Burns : Journal of the International Society for Burn Injuries·Abdelraouf A ElmanamaGhassan A Tayh
Jun 4, 2013·South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie·Emile CoetzeeDelawir Kahn
Oct 4, 2014·Clinical Microbiology Reviews·Karsten BeckerGeorg Peters
Nov 13, 2014·Journal of Infection in Developing Countries·Nasih OthmanParihan Yahya Rashid
Jun 9, 2015·Burns : Journal of the International Society for Burn Injuries·I A BahemiaC N Menezes
Jan 19, 2016·Burns : Journal of the International Society for Burn Injuries·J DokterH Boxma
Jun 1, 2016·Burns : Journal of the International Society for Burn Injuries·Jian FransénHåkan Hanberger
Jun 28, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M EmaneiniR Beigverdi

❮ Previous
Next ❯

Citations

Aug 3, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Alessio StrazzullaSylvain Diamantis
May 10, 2020·BioMed Research International·Wafa F S BadullaMohamed Izham Mohamed Ibrahim
Nov 21, 2020·Viruses·Jacek BajGrzegorz Teresiński
Jul 20, 2021·Frontiers in Cellular and Infection Microbiology·Yali GongHaisheng Li
Jul 9, 2021·Journal of Burn Care & Research : Official Publication of the American Burn Association·Mohammad HashemzadehPejman Bakhtiyariniya
Aug 31, 2021·Burns and Trauma·Kenji Hayashida, Sho Yamakawa

❮ Previous
Next ❯

Software Mentioned

SPSS
WHONET

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Acinetobacter Infections

Acinetobacter infections have become common in hospitalized patients, especially in the intensive care unit setting and are difficult to treat due to their propensity to develop antimicrobial drug resistance. Discover the latest research on Acinetobacter Infections here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.